Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Science
Denis Campbell Health policy editor

Vaccine shown to prolong life of patients with aggressive brain cancer

A CT scan of glioblastoma
Glioblastoma is the commonest form of brain cancer and also one of the most aggressive, with people on average living 12-18 months after diagnosis. Photograph: Dr P Marazzi/Science Photo Library/Getty Images/Science Photo Library RF

The world’s first vaccine to treat deadly cancerous brain tumours can potentially give patients years of extra life, a global clinical trial has concluded.

A senior NHS doctor who was one of the trial’s chief investigators said the evidence showed DCVax had resulted in “astonishing” enhanced survival for patients.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.